ProFund Advisors »

Rapport Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $269k 8.9k 30.34

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Netflix (NFLX)
Palantir Technologies Cl A (PLTR)
Cisco Systems (CSCO)
Costco Wholesale Corporation (COST)

View all positions for ProFund Advisors

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics